Accessibility Menu
Terumo logo

Terumo(OTC) TRUMY

Market Cap$22.94BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2009)+269%
5 Year-30%
1 Year-12%
1 Month+6%
$15.80
+1.61%
+0.25Today
Terumo last closing stock price
MetricPriceDate
Last closeUSD 15.552026-09-02
Terumo stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.36%USD 16.092026-08-26
1 month+6.28%USD 14.632026-08-03
3 month+8.82%USD 14.292026-06-04
Year to date+8%USD 14.402025-12-31
1 year-11.99%USD 17.672025-09-02
3 year+6.69%USD 14.572023-09-01
5 year-29.99%USD 22.212021-09-03
Since inception+269.41%USD 4.212009-02-04

Terumo Financials at a Glance

Market Cap

$22.94BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥1.20T

Net Income (TTM)

¥166.18B

EPS (TTM)

$0.72

P/E Ratio

21.65

Dividend

$0.19

Beta (Volatility)

0.66 (Low)

Price

$15.80

Volume

48,361

Open

$15.88

Previous Close

$15.80

Daily Range

$15.75 - $15.88

52-Week Range

$12.08 - $18.60

Estimated Earnings Date

Nov 11, 2026

TRUMY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Terumo

Terumo Corporation is a global medical technology company focused on manufacturing and selling a diverse range of medical products and equipment. The company operates through three main segments: Cardiac and Vascular, Medical Care Solutions, and Blood and Cell Technologies.

Products and Services
  • Cardiac and vascular devices for interventions and treatments
  • General medical products including syringes and infusion systems
  • Innovative blood and cell management solutions
Growth Outlook
  • Revenue increased to JPY 315.92 billion in Q1 2026
  • Net income rose to JPY 70.43 billion, reflecting strong operational efficiency
  • Positive cash flow from operations at JPY 74.48 billion in Q1 2026
Financial Highlights
  • Trailing twelve-month revenue of JPY 1.23 trillion
  • Net profit margin of 13.90% indicates solid profitability
  • Dividend yield of 1.16% provides attractive returns to shareholders
Terumo Corporation has established itself as a leader in the medical technology sector, with a strong focus on innovation and quality. The company's diverse product offerings cater to various medical needs, positioning it well for future growth. Recent financial performance highlights a robust revenue trajectory and profitability, underscoring the effectiveness of its operational strategies. The positive cash flow from operations further enhances the company's financial stability, making it an appealing option for potential investors. With a commitment to advancing healthcare solutions, Terumo Corporation is poised for continued success in the evolving medical landscape.
AI Generated • Aug 21, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

31,185

CEO

Hikaru Samejima, MBA

Website

www.terumo.co.jp

Headquarters

Tokyo, TY 151-0072, JP

TRUMY Financials

Key Financial Metrics (TTM)

Gross Margin

53.03%

Operating Margin

16.90%

Net Income Margin

13.90%

Return on Equity

10.60%

Return on Capital

9.93%

Return on Assets

6.93%

Earnings Yield

4.62%

Dividend Yield

1.21%

Payout Ratio

26.87%

Stock Overview

Market Cap

$22.94BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.48B

Volume

48.36K

Avg. Volume

112.77K

Financials (TTM)

Gross Profit

¥638.17B

Operating Income

¥203.35B

EBITDA

¥303.38B

Operating Cash Flow

¥276.87B

Capital Expenditure

-¥82.33B

Free Cash Flow

¥194.54B

Cash & ST Invst.

¥314.63B

Total Debt

¥438.06B

Terumo Performance Analysis

Terumo annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31JPY 6,054,862,693-3.3%
20242024-03-31JPY 6,383,499,4035.4%
20252025-03-31JPY 6,796,776,0386.5%
20262026-03-31JPY 7,511,190,78610.5%
Terumo sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-307.6%
Q32025-12-317.9%
Q42026-03-311.3%
Q12026-06-303.3%
Terumo annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31JPY 0.44-15.9%
20242024-03-31JPY 0.4912.7%
20252025-03-31JPY 0.524.7%
20262026-03-31JPY 0.6118.0%
Terumo sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-15.4%
Q32025-12-31-8.5%
Q42026-03-31-19.9%
Q12026-06-30171.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

¥315.92B

+21.5%

Gross Profit

¥180.89B

+24.4%

Gross Margin

57.26%

N/A

Market Cap

$22.94BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$759.35K

N/A

Employees

30,207

N/A

Net Income

¥70.43B

+68.3%

EBITDA

¥97.29B

+26.2%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

¥314.63B

+54.0%

Total Debt

¥438.06B

+109.7%

Accounts Receivable

¥223.90B

+23.0%

Inventory

¥341.11B

+13.3%

Long Term Debt

¥248.82B

+90.2%

Short Term Debt

¥189.24B

+142.3%

Return on Assets

6.93%

N/A

Return on Invested Capital

10.20%

N/A

Free Cash Flow

¥61.87B

+295.5%

Operating Cash Flow

¥74.48B

+128.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SDMHFSartorius Stedim Biotech S.A.
$229.00+0.00%
SAUHFStraumann Holding AG
$118.73+4.15%
SAUHYStraumann Holding AG
$11.77-0.17%
SUVPFSartorius AG
$270.29+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
NVDANvidia
$228.45+0.02%
SPCXSpace Exploration Technologies
$149.74+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$11.01+0.06%

Questions About TRUMY

What is the current price of Terumo?

Terumo is trading at $15.80 per share.

What is the 52-week range for Terumo?

Over the past 52 weeks, Terumo has traded between $12.08 and $18.60.

How much debt does Terumo have?

As of the most recent reporting period, Terumo reported total debt of ¥2.40B.

How much cash does Terumo have on hand?

Terumo reported ¥1.94B in cash and cash equivalents in its most recent financial results.

What is Terumo’s dividend yield?

Terumo currently has a dividend yield of 1.21%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services